Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts - 2Step by step instructions to Pick the Right Sunlight powered charger Type for Your Home
- 3More parents refusing vitamin K shots for newborns, study finds
- 42026 will be the year NASA astronauts fly around the moon again — if all goes to plan
- 5How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
- The Main 15 Applications for Efficiency and Association
- Top 20 Compelling Business Books for Progress
- Presenting Nintendo's New Pastel Satisfaction Con Tones for Switch Gamers: 3 Upscale Choices
- Grasping the Course of Evacuation and Extradition in U.S. Migration
- What to know about King Charles III's cancer treatment and his message to the public
- Visual communication Programming for Fledglings
- Audits of Espresso Types: Which Mix Is for You?
- 7 Logically Demonstrated Techniques for Better Rest
- Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video)
